Sumitovant Biopharma Ltd. - Net Worth and Insider Trading

Sumitovant Biopharma Ltd. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Sumitovant Biopharma Ltd. owns 2 companies in total, including Myovant Sciences Ltd (MYOV) , and Urovant Sciences Ltd (UROV) .

Click here to see the complete history of Sumitovant Biopharma Ltd.’s form 4 insider trades.

Insider Ownership Summary of Sumitovant Biopharma Ltd.

Ticker	Comapny	Transaction Date	Type of Owner
MYOV	Myovant Sciences Ltd	2019-12-27	10 percent owner
UROV	Urovant Sciences Ltd	2020-02-19	10 percent owner

Sumitovant Biopharma Ltd. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Sumitovant Biopharma Ltd. Ownership Network

Ownership Network List of Sumitovant Biopharma Ltd.

No Data

Ownership Network Relation of Sumitovant Biopharma Ltd.

Sumitovant Biopharma Ltd. Owned Company Details

What does Myovant Sciences Ltd do?

Who are the key executives at Myovant Sciences Ltd?

Sumitovant Biopharma Ltd. is the 10 percent owner of Myovant Sciences Ltd. Other key executives at Myovant Sciences Ltd include 10 percent owner Sumitomo Chemical Co., Ltd. , Chief Commercial Officer Lauren Merendino , and General Counsel & Corp. Secy. Matthew Lang .

Myovant Sciences Ltd (MYOV) Insider Trades Summary

Over the past 18 months, Sumitovant Biopharma Ltd. made no insider transaction in Myovant Sciences Ltd (MYOV). Other recent insider transactions involving Myovant Sciences Ltd (MYOV) include a net sale of 4,051 shares made by Matthew Lang , a net sale of 3,360 shares made by Ferreira Juan Camilo Arjona , and a net purchase of 51,599,200 shares made by Sumitomo Chemical Co., Ltd. .

In summary, during the past 3 months, insiders sold 0 shares of Myovant Sciences Ltd (MYOV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 19,697 shares of Myovant Sciences Ltd (MYOV) were sold and 51,599,200 shares were bought by its insiders, resulting in a net purchase of 51,579,503 shares.

Myovant Sciences Ltd (MYOV)'s detailed insider trading history can be found in Insider Trading Tracker table.

Myovant Sciences Ltd Insider Transactions

No Available Data

Sumitovant Biopharma Ltd. Mailing Address

Above is the net worth, insider trading, and ownership report for Sumitovant Biopharma Ltd.. You might contact Sumitovant Biopharma Ltd. via mailing address: C/o Roivant Sciences, Inc., 320 West 37th Street, 5th Floor, New York Ny 10018.

Discussions on Sumitovant Biopharma Ltd.

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.